Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Financial Position

v3.24.1
Consolidated Statements of Financial Position - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Current:    
Cash and cash equivalents $ 6,831 $ 12,449
Restricted cash 70 439
Accounts receivable, net 907 2,252
Prepaids, deposits and other receivables 1,649 2,708
Inventories, net 4,483 8,399
Total current assets 13,940 26,247
Investment – Cansativa 0 5,679
Property, plant and equipment, net of accumulated depreciation of $8,793 and $7,120 for the years ended December 31, 2023 and 2022, respectively 12,321 13,963
Land held for sale 1,500 1,500
Intangible assets, net 2,653 3,354
Operating lease right-of-use assets, net 829 1,303
Other non-current assets 0 52
Total Assets 31,243 52,098
Current:    
Accounts payable 2,063 2,299
Accrued expense and other current liabilities 2,844 4,238
Loans and borrowings, current portion 498 465
Warrant liability 0 113
Operating lease liabilities, current portion 386 1,239
Deferred revenue 20 1,072
Total current liabilities 5,811 9,426
Loans and borrowings 720 1,065
Operating lease liabilities — long-term 483 1,087
Other long-term liabilities 12 112
Total Liabilities 7,026 11,690
Contingencies and commitments
Shareholders’ equity    
Preferred shares, without par value, unlimited shares authorized, nil shares issued and outstanding for each of December 31, 2023 and 2022 0 0
Common shares, without par value, unlimited shares authorized: 1,727,698 and 1,454,559 shares issued and outstanding as of December 31, 2023 and 2022, respectively 0 0
Additional paid-in capital 223,021 221,313
Accumulated deficit (198,804) (180,905)
Total shareholders' equity 24,217 40,408
Total liabilities and shareholders' equity $ 31,243 $ 52,098